Literature DB >> 18541226

HIV-1 Tat protein induces IL-10 production by an alternative TNF-alpha-independent pathway in monocytes: role of PKC-delta and p38 MAP kinase.

Kaoutar Leghmari1, Yamina Bennasser, Jean Tkaczuk, Elmostafa Bahraoui.   

Abstract

HIV-1 Tat protein stimulates the production of both TNF-alpha and IL-10 in human monocytes. Taking into account the ability of TNF-alpha to induce IL-10 production, we evaluated the link between Tat, TNF-alpha and IL-10 and the implication of PKC and p38 MAP kinase pathways. Our data showed that (i) in the presence of neutralizing anti-TNF-alpha antibodies, IL-10 production is only partially inhibited; (ii) in a calcium-free medium, while TNF-alpha production is totally inhibited, Tat continues to induce IL-10; (iii) under these conditions, Tat-mediated IL-10 production is associated with PKC-delta activation; and (iv) downstream of PKC, p38 MAP kinase is crucial for TNF-alpha independent IL10 production. Overall, our data suggest a new mechanism, implicating Tat protein, by which HIV-1 may maintain a constant production of the immunosuppressive IL-10 cytokine, even in the absence of TNF-alpha production. In consequence, HIV-1 may escape immune surveillance and thus promote the establishment of an immunosuppressive state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541226     DOI: 10.1016/j.cellimm.2008.04.015

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  21 in total

Review 1.  Signaling through the P38 and ERK pathways: a common link between HIV replication and the immune response.

Authors:  Robert L Furler; Christel H Uittenbogaart
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

2.  HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.

Authors:  Rémi Planès; Nawal Ben Haij; Kaoutar Leghmari; Manutea Serrero; Lbachir BenMohamed; Elmostafa Bahraoui
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

3.  Target of HIV-1 Envelope Glycoprotein gp120-Induced Hippocampal Neuron Damage: Role of Voltage-Gated K(+) Channel Kv2.1.

Authors:  Qing Zhu; Xu Song; Jing Zhou; Yixin Wang; Jianxun Xia; Wenyi Qian; Jingying Zhu; Rong Gao; Jun Wang; Hang Xiao
Journal:  Viral Immunol       Date:  2015-09-22       Impact factor: 2.257

4.  Calcium/calmodulin-dependent protein kinase (CaMK) Ialpha mediates the macrophage inflammatory response to sepsis.

Authors:  Xianghong Zhang; Lanping Guo; Richard D Collage; Jennifer L Stripay; Allan Tsung; Janet S Lee; Matthew R Rosengart
Journal:  J Leukoc Biol       Date:  2011-03-03       Impact factor: 4.962

5.  Therapeutic doses of irradiation activate viral transcription and induce apoptosis in HIV-1 infected cells.

Authors:  Sergey Iordanskiy; Rachel Van Duyne; Gavin C Sampey; Caitlin M Woodson; Kelsi Fry; Mohammed Saifuddin; Jia Guo; Yuntao Wu; Fabio Romerio; Fatah Kashanchi
Journal:  Virology       Date:  2015-07-14       Impact factor: 3.616

6.  FR167653, a p38 mitogen-activated protein kinase inhibitor, aggravates experimental colitis in mice.

Authors:  Takashi Nishimura; Akira Andoh; Atsushi Nishida; Makoto Shioya; Yuhsuke Koizumi; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

7.  Interleukin (IL)-32β-mediated CCAAT/enhancer-binding protein α (C/EBPα) phosphorylation by protein kinase Cδ (PKCδ) abrogates the inhibitory effect of C/EBPα on IL-10 production.

Authors:  Jeong-Woo Kang; Yun Sun Park; Man Sub Kim; Dong Hun Lee; Yesol Bak; Sun Young Ham; Soo Ho Park; Jin Tae Hong; Do-Young Yoon
Journal:  J Biol Chem       Date:  2013-06-30       Impact factor: 5.157

8.  Intrathecal injection of adenosine 2A receptor agonists reversed neuropathic allodynia through protein kinase (PK)A/PKC signaling.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Jacqueline A Harrison; Rachael Rzasalynn; Paige Sholar; Jayson Rieger; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2013-06-28       Impact factor: 7.217

9.  Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders.

Authors:  Dawn Eggert; Prasanta K Dash; Nawal Serradji; Chang-Zhi Dong; Pascal Clayette; Francoise Heymans; Huanyu Dou; Santhi Gorantla; Harris A Gelbard; Larisa Poluektova; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2009-06-21       Impact factor: 3.478

Review 10.  HIV interactions with monocytes and dendritic cells: viral latency and reservoirs.

Authors:  Christopher M Coleman; Li Wu
Journal:  Retrovirology       Date:  2009-06-01       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.